loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

Approved Drug Products containing 210279 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 ADARE PHARMS INC (8)

filter

01 CAPSULE, EXTENDED RELEASE;ORAL (8)

filter

01 RX (8)

filter

01 DEXMETHYLPHENIDATE HYDROCHLORIDE (8)

filter

01 No (8)

URL Supplier Web Content
CAPSULE, EXTENDED ...
20MG
2018-10-09
210279
DEXMETHYLPHENIDATE...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED ...
10MG
2018-10-09
210279
DEXMETHYLPHENIDATE...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED ...
35MG
2018-10-09
210279
DEXMETHYLPHENIDATE...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED ...
25MG
2018-10-09
210279
DEXMETHYLPHENIDATE...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED ...
15MG
2018-10-09
210279
DEXMETHYLPHENIDATE...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED ...
5MG
2018-10-09
210279
DEXMETHYLPHENIDATE...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED ...
40MG
2018-10-09
210279
DEXMETHYLPHENIDATE...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED ...
30MG
2018-10-09
210279
DEXMETHYLPHENIDATE...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 210279

Looking for FDA Orange Book APPLICATION 210279 8

19

Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.

One of their notable products is DEXMETHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 210279.

Regulatory Information RX

With a dosage strength 20MG

Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL

Reference Listed Drug No

Approved since 2018-10-09

Therapeutic Equivalence (TE) Code AB

18

Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.

One of their notable products is DEXMETHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 210279.

Regulatory Information RX

With a dosage strength 10MG

Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL

Reference Listed Drug No

Approved since 2018-10-09

Therapeutic Equivalence (TE) Code AB

17

Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.

One of their notable products is DEXMETHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 210279.

Regulatory Information RX

With a dosage strength 35MG

Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL

Reference Listed Drug No

Approved since 2018-10-09

Therapeutic Equivalence (TE) Code AB

16

Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.

One of their notable products is DEXMETHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 210279.

Regulatory Information RX

With a dosage strength 25MG

Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL

Reference Listed Drug No

Approved since 2018-10-09

Therapeutic Equivalence (TE) Code AB

15

Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.

One of their notable products is DEXMETHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 210279.

Regulatory Information RX

With a dosage strength 15MG

Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL

Reference Listed Drug No

Approved since 2018-10-09

Therapeutic Equivalence (TE) Code AB

14

Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.

One of their notable products is DEXMETHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 210279.

Regulatory Information RX

With a dosage strength 5MG

Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL

Reference Listed Drug No

Approved since 2018-10-09

Therapeutic Equivalence (TE) Code AB

13

Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.

One of their notable products is DEXMETHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 210279.

Regulatory Information RX

With a dosage strength 40MG

Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL

Reference Listed Drug No

Approved since 2018-10-09

Therapeutic Equivalence (TE) Code AB

12

Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.

One of their notable products is DEXMETHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 210279.

Regulatory Information RX

With a dosage strength 30MG

Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL

Reference Listed Drug No

Approved since 2018-10-09

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY